Puzzle in Wednesday order on duty exemption

One of the 3 reversals on removal of customs concession is for a drug whose Sun Pharma generic is market leader

Half of online drug orders end up getting cancelled

To boost imports and avoid further public pressure, the government on Wednesday restored customs duty exemptions on three life-saving drugs. However, it is not clear why the government selected Octreotide as one of the three, where India’s leading drug maker, Sun Pharmaceutical Industries, has a leading market share. According to the latest data of IMS Health, a global information and technology services company, Sun, which makes this drug at its Halol (Gujarat) unit and sells it under the brand name of Octride, has a market share of 63 per cent. However, according to AIOCD AWACS, ...